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Abstract
MicroRNAs (miRNAs) are small non-coding RNAs that function as post-transcriptional modulators by regulating stability or
translation of target mRNAs. Recent studies have implicated miRNAs in the regulation of mammalian circadian rhythms. To
explore the role of miRNAs in the post-transcriptional modulation of core clock genes in the master circadian pacemaker, we
examined miR-142-3p for evidence of circadian expression in the suprachiasmatic nuclei (SCN), regulation of its putative
clock gene target Bmal1 via specific binding sites in the 39 UTR and overexpression-induced changes in the circadian rhythm
of BMAL1 protein levels in SCN cells. In mice exposed to constant darkness (DD), miR-142-3p levels in the SCN were
characterized by circadian rhythmicity with peak expression during early subjective day at CT 3. Mutagenesis studies
indicate that two independent miRNA recognition elements located at nucleotides 1–7 and 335–357 contribute equally to
miR-142-3p-induced repression of luciferase-reported Bmal1 39 UTR activity. Importantly, overexpression of miR-142-3p in
immortalized SCN cells abolished circadian variation in endogenous BMAL1 protein levels in vitro. Collectively, our results
suggest that miR-142-3p may play a role in the post-transcriptional modulation of Bmal1 and its oscillatory regulation in
molecular feedback loops mediating SCN circadian function.
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Introduction
In mammals, the suprachiasmatic nuclei (SCN) of the anterior
hypothalamus function as the master pacemaker mediating the
generation and light-dark entrainment of circadian rhythms [1,2].
In addition to coordinating circadian rhythmicity in other brain
regions and peripheral tissues, the SCN is characterized by
ensemble and cell-autonomous circadian oscillations in many of its
cellular and molecular processes independent of external input [3–
7]. These endogenous oscillations are especially prevalent in the
expression of genes comprising the molecular clockworks and are
thus vital to the circadian oscillator and pacemaking functions of
the SCN. The circadian clock mechanism common to both SCN
and peripheral cells consists of feedback interactions between
brain, muscle ARNT-like protein 1 (Bmal1), circadian locomotor
output cycles kaput (Clock), as well as the period (Per1 and Per2) and
cryptochrome (Cry1 and Cry2) genes in which the transcription of
these core molecular components is rhythmically regulated by
their protein products with exception of Clock [8–13].
While post-translational processes including phosphorylation,
ubiquitination, sumoylation, and acetylation have garnered the
most attention for their role in the regulation of circadian feedback
loops [14,15], recent studies have revealed that post-transcrip-
tional mechanisms are also involved in the modification of clock
proteins and oscillatory behavior of core molecular components
[16,17]. In this regard, emerging evidence suggests that micro-
RNAs (miRNAs) may contribute to the post-transcriptional
modulation of circadian clock function. Mature miRNAs are
small non-coding RNAs, usually 19–25 nucleotides in length, and
their interactions with miRNA-recognition elements (MRE’s) in
the 39 untranslated regions (UTR) of target genes induce mRNA
de-stabilization and/or translational repression [18–21]. The
potential role of miRNAs in SCN clock control of circadian
rhythms was first observed in experiments indicating that miR-219
and miR-132 expression in the SCN oscillates in a circadian
manner and antagonism of these miRNAs respectively alters the
circadian period and light-induced phase shifts of the activity
rhythm in mice [22]. It is noteworthy that miRNAs have also been
implicated in the modulation of peripheral circadian clocks as
antisense inhibition of miR-122 has been shown to induce post-
transcriptional perturbations in the circadian expression of many
genes involved in hepatic lipid and cholesterol metabolism [23].
Despite the increasing focus on miRNA function in the
regulation of mammalian circadian rhythms, limited information
is available on whether specific miRNAs target key components of
the molecular clockworks and contribute to the oscillatory
regulation of clock gene transcripts. In Drosophila, bantam encodes
a miRNA that has been shown to regulate the translation of clock
via interactions with multiple target sites within the 39 UTR of this
gene [24]. In mammals, the miR-192/194 cluster has been
identified as a potent repressor of the 39 UTRs of all Per genes
[25]. Because miR-142-3p is distinguished by robust modulation
of Bmal1 39 UTR activity in mammalian peripheral oscillators [26]
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and by the presence of a canonical, CACGTG E-box element in
its promoter region that may provide for clock control of miR-142
transcription, the present study focused on the role of this miRNA
in the post-transcriptional regulation of Bmal1 in the master
circadian clock within the SCN. The objectives of our experi-
mental analysis were to determine whether: 1) miR-142-3p is
rhythmically expressed in the SCN in vivo and in an immortalized
SCN cell line; 2) the repression of Bmal1 39 UTR activity in
response to miR-142-3p overexpression is abated by mutagenesis
of specific miRNA binding sites; and 3) miR-142-3p overexpres-
sion affects the endogenous BMAL1 protein rhythm in SCN cells
in vitro.
Materials and Methods
Experiment 1: Temporal Profiling of miR-142-3p
Expression in SCN cells in vivo and in vitro
Animals and SCN tissue collection. Experimental subjects
were 40 male C57BL/6J mice at 6–8 weeks of age (JAX Mice &
Services, Bar Harbor, ME). Animals were maintained in the
vivarium at Texas A&M University System Health Science Center
under a standard 12h light: 12 h dark cycle (LD 12:12; lights-on at
0600 h). Animals were housed 4–5 per cage with ad libitum access
to food and water, and periodic animal care was performed at
random times. All procedures used in this study were approved by
the University Laboratory Animal Care Committee at Texas
A&M University.
To determine whether miR-142-3p expression fluctuates
rhythmically in the SCN in vivo, mice were maintained in LD
12:12 for 3 weeks prior to experimental analysis and then exposed
to constant darkness (DD) beginning at lights-off in the LD 12:12
cycle (1800 h). Beginning 15 hours later (0900 h or circadian time
[CT] 3), animals were sacrificed at 4 h intervals (n=5) for 24 h by
decapitation using an infrared viewer (FJW Optical Systems,
Palatine, IL). SCN tissue was immediately dissected as described
previously [27,28]. All tissue samples were frozen in liquid
nitrogen and stored at 280uC until further processing.
For in vitro analysis, immortalized SCN cell lines generated from
mPer2Luc knockin and from mice with targeted disruption of Per1
and Per2 (Per1ldc/Per2ldc) were used to profile the temporal pattern
of miR-142-3p expression. These cell lines were maintained and
propagated as described previously [29]. Briefly, cells were grown
on laminin-coated 60 mm dishes (Corning, Inc.) in Minimal
Essential Medium (MEM; Invitrogen, Grand Island, NY)
containing 10% Fetal Bovine Serum (FBS), 3000 mg/ml glucose
and 292 mg/ml L-glutamine. Fresh medium was applied every
48 h and cultures were split 1:3 to 1:5 every 3–4 days. Prior to
experimentation, cells were expanded onto laminin-coated 6-well
plates (BD Biosciences, San Jose, CA). Approximately 24 h after
plating, the medium was changed so as to reduce the FBS
concentration to 5% and on the following day cells were rinsed
with calcium-magnesium free (CMF) phosphate-buffered saline
and then cultured in serum-free Neurobasal medium containing
B27 supplement (1X, Invitrogen). Cultures (n = 5) were harvested
at 4 h intervals for 36 h by trypsinization and cell pellets were flash
frozen in liquid nitrogen. All samples were stored at 280uC until
subsequent analysis of miRNA or mRNA content.
RNA extraction and Real-time PCR. Total cellular RNA
was later extracted from individual mouse SCN tissue samples and
cultures of mPer2Luc and Per1ldc/Per2ldc SCN cells using miRNeasy
kit (Qiagen, Inc., Valencia, CA) according to the manufacturer’s
protocols. Total RNA was estimated using a Nanodrop ND2000
(Thermo Scientific, Rockford, IL). Quantitative real-time PCR
analysis for miR-142-3p was conducted using Taqman microRNA
assays (Applied Biosystems) as described previously [26]. Briefly,
miR-142-3p from individual samples was reverse transcribed using
Taqman MicroRNA Reverse Transcription Kit and the cDNA
equivalent of 1.5 ng of total RNA was PCR amplified in an ABI
PRISM 7500 Fast sequence detection system using the following
standard conditions: 1) heating at 95uC for 10 min, and 2)
amplification over 40 cycles at 95uC for 15 sec and 60uC for
1 min. As an endogenous control for differences in sample RNA
content and reverse-transcription efficiencies, U6 snRNA was also
amplified from the same samples using identical parameters. Using
the comparative CT method described in the ABI Prism 7700
Sequence Detection System User Bulletin #2 (PE-ABI), the
relative abundance of miR-142-3p was calculated by normaliza-
tion first to corresponding U6 snRNA levels in each sample and
then to a calibrator consisting of pooled cDNA from multiple
samples over the entire time series.
Relative quantification of Bmal1 mRNA abundance in all
samples was performed using SYBR-Green real-time PCR
technology (ABI) as described previously [30,31]. To generate
single-strand cDNAs, total RNA (1 mg) from individual samples
was reverse transcribed using random hexamers and Superscript
III reverse transcriptase Kit (Invitrogen). Real-time PCR analysis
was performed on duplicate aliquots using the cDNA equivalent of
1 ng of total RNA for each sample. The PCR cycling conditions
were: 1) serial heating at 50uC for 2 min and 95uC for 10 min, 2)
amplification over 40 cycles at 95uC for 15 sec and 60uC for
1 min, and 3) dissociation at 95uC for 15 sec, 60uC for 1 min,
95uC for 15 sec and 60uC for 15 sec. To control for differences in
sample RNA content, cyclophilin A (Ppia) was amplified with the
cDNA equivalent of 1 ng total RNA from the same samples.
Consistent with our previous studies using this gene in a similar
manner [31,32], Ppia showed no sign of circadian or ultradian
variation (data not shown). The comparative CT method was
similarly applied to determine the relative expression of Bmal1
mRNA.
The following primers were used for real-time PCR analysis:
Bmal1 forward: 59- CCAAGAAAGTATGGACACAGACAAA-
39;
Bmal1 reverse: 59- GCATTCTTGATCCTTCCTTGGT-39;
Ppia forward: 59- TGTGCCAGGGTGGTGACTT-39;
Ppia reverse: 59- TCAAATTTCTCTCCGTAGATGGACTT-
39.
Experiment 2: Mutagenic Analysis of Putative Binding
Sites Mediating miR-142-3p-induced Repression of Bmal1
39 UTR Activity
Bmal1 39 UTR luciferase reporter
constructs. miTargetTM miRNA Target Sequence 39 UTR
Expression Clone containing Bmal1 39 UTR sequence (Accession:
NM_007489.3) inserted in the pEZX-MT01 vector was purchased
from GeneCopoeia, Inc (Rockville, MD). The plasmid was
propagated using methods established in our previous study
[26]. Deletions in predicted miR-142-3p binding sites on the
Bmal1 39 UTR were generated using QuikChange II XL Site-
Directed Mutagenesis Kit (Stratagene, La Jolla, CA) according to
the manufacturer’s protocols. Briefly, the full-length Bmal1 39
UTR was PCR mutagenized using specific primers so as to delete
nucleotides 1–7 complementary to miR-142-3p seed region. After
Dnp1-mediated degradation of parental plasmid DNA, the
mutagenized plasmid was transformed into XL10-Gold Ultra-
competent cells (Stratagene) and transformants were selected on
kanamycin-containing (final conc. = 50 mg/ml) imMedia agar
plates (Invitrogen). A single colony was isolated and propagated in
imMedia Kan+ liquid medium (final conc. = 50 mg/ml). The
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plasmid was extracted using HiSpeed Plasmid Midi Kit (Qiagen,
Inc.) and then sequenced to verify the targeted deletion (Bmal1
c.1_7del). Identical methods were also used to delete nucleotides
335–357 corresponding to a second predicted miR-142-3p binding
site on the Bmal1 39 UTR complementary to the seed region along
with additional nucleotides that may function as a 39 supplemen-
tary or compensatory element and aid in miRNA biological
activity [33–35]. The resulting plasmid (Bmal1 c.335_357del) was
then subjected to a second round of mutagenesis to provide for
additional deletion of nucleotides 1–7. The plasmid with targeted
deletions of both miR-142-3p target sites on the Bmal1 39 UTR
(Bmal1 c.1_7del+c.335_357del) was propagated and sequenced to
verify these deletions as described above. The miRNA 39 UTR
target control vector (Genecopoeia; CmiT000001-MT01), con-
sisting of the pEZX-MT01 vector backbone without any 39 UTR
sequence, was used to determine the specificity of miRNA
interactions with the full-length and mutagenized Bmal1 vectors.
miR-142-3p-mediated regulation of Bmal1 39 UTR was analyzed
in human embryonic kidney (HEK293) cells using established
methods [26]. Briefly, cells were seeded onto 24-well plates
(Corning, Inc., Tewksbury MA) and 24 h later were co-transfected
with pEZX-MR04 miR-142 expression vector (miExpress Precur-
sor miRNA expression clone; Genecopoeia, Inc., MmiR3437-
MR04) and with either the target control, full-length Bmal1 39
UTR (WT), Bmal1 c.1_7del, Bmal1 c.335_357del or Bmal1
c.1_7del+c.335_357del miRNA 39 UTR target clones. As an
additional control for specificity of the deletion, cells were also
co-transfected with miR-494 expression vector and either the
target control, Bmal1 or Bmal1 c.1_7del+c.335_357del miRNA 39
UTR target clones. Following transfection for 5 hours, cells were
rinsed and growth medium was replaced. Forty-eight hours later,
cell lysates of HEK293 cultures from all treatment groups (n = 4)
were prepared using Passive Lysis Buffer (Promega Corp.,
Madison, WI). Firefly and Renilla luciferase activity from individual
samples was then analyzed using the dual-luciferase reporter assay
system (Promega Corp.). Luminescence was measured on Syner-
gy2 microplate luminometer (BioTek, Winooski, VT) and reported
as the ratios of firefly luciferase signal normalized to Renilla
luciferase activity in the same sample.
Experiment 3: Effects of miR-142-3p Overexpression on
the Circadian Regulation of BMAL1 Protein Levels in SCN
cells in vitro
The effects of miR-142-3p overexpression on endogenous levels
of mBMAL1 protein were examined in cultures of mPer2Luc SCN
cells that were derived from a single passage. mPer2Luc SCN cells
were expanded on laminin-coated 60-mm dishes (Corning, Inc.)
maintained at 37uC and 5% CO2 in MEM (Invitrogen, Inc.)
supplemented with 3000 mg/ml D-glucose, 292 mg/ml L-gluta-
mine and 10% Fetal Bovine Serum (Hyclone). Prior to experi-
mentation, cells were seeded onto laminin-coated 6-well plates and
24 h later, cultures were transfected with pEZX-MR04 miRNA
expression vector for miR-142 (final conc. = 4.0 mg/well) using
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
guidelines. Control cultures were similarly transfected with a
pEZX-MR04 vector encoding a scrambled, non-targeting control
sequence. Based on preliminary observations derived from
fluorescence microscopy examining the expression of the eGFP
reporter encoded in both pEZX-MR04 vectors (miR-142 expres-
sion and scrambled, non-targeting control), the transfection
efficiency in mPer2Luc SCN cells ranged from 40–50%. Following
transfection for 5 h, cells were rinsed and cultured in growth
medium supplemented with 5% FBS. On the following day, cells
were rinsed with CMF buffer and then maintained in serum-free
Neurobasal medium containing B27 supplement (1X, Invitrogen).
Beginning 12 h later, control- and miR-142-3p-transfected
cultures (n = 5) were harvested at 4 h intervals for 24 h by
trypsinization and cell pellets were flash frozen in liquid nitrogen.
All samples were stored at 280uC until subsequent processing.
Cell pellets were sonicated in mammalian protein extraction
reagent (MPER; Pierce Biotechnology, Inc., Rockford, IL)
supplemented with protease inhibitor cocktail (PMSF), and protein
content in cell homogenate samples was measured using the
bicinchoninic acid method (BCA Protein Assay Kit; Thermo
Scientific Pierce).
Western blotting. BMAL1 protein levels in SCN cell lysates
were assessed by Western blot analysis using the XCell
SureLockTM Mini-cell and Novex Western Transfer Apparatus
(Invitrogen). Samples were loaded at,20 mg protein per lane onto
10% Tris-Glycine gels. Following separation at 125 V for 2 h,
proteins were transferred onto 0.45 mm nitrocellulose membranes
(Invitrogen) and blocked at room temperature for 1 hour with 5%
skimmed milk in Tris-buffered saline (TBS) supplemented with
0.1% Tween-20 (TBS-T). With interceding rinses in TBS-T,
membranes were probed overnight at 4uC with rabbit anti-
BMAL1 (1:250; Abcam, Cambridge, MA) or a mouse monoclonal
antibody against b-actin (1:1000; Sigma-Aldrich Corp., St. Louis,
MO) followed by a 1-hour incubation with horse-radish peroxi-
dase (HRP)-conjugated donkey anti-rabbit IgG (1:1000) or goat
anti-mouse IgG (1:2000; Jackson ImmunoResearch Laboratories,
Inc., West Grove, PA). Immunoreactive signal for BMAL1 was
generated using enhanced chemiluminescence (ECL) reagent
(Thermo Scientific Pierce) and luminescence for size-appropriate
bands was detected using a FluorChem Gel imaging system (Alpha
Innotech Corp., San Leandro, CA). To control for differences in
protein content between samples, signal intensity measurements
for BMAL1 were normalized to the values for b-actin in each
sample. Using NIH ImageJ software, densitometric analyses for
immunoreactive bands were performed on data derived from five
biological replicates and two technical replicates.
Statistical analyses. Circadian fluctuations in miR-142-3p
and Bmal1 mRNA expression were identified by cosine curve-
fitting analysis using GraphPad Prism software. With a=0.05,
waveform fittings with p-values #0.01 were considered statistically
significant and therefore characterized by circadian variation.
Paired comparisons between peak and trough values were
analyzed post hoc for statistical differences using the Student
Newman-Keuls sequential range test. The a-value was set at 0.05
for these post hoc analyses.
Independent t-tests were performed on normalized luciferase
bioluminescence data to determine the significance of miRNA-
mediated repression of luciferase-reported Bmal1 39 UTR activity.
The a-value was set at 0.05 for all independent t-tests. Temporal
patterns of BMAL1 protein expression were first analyzed by one-
way analysis of variance (ANOVA). Paired comparisons between
peak values and those observed during the preceding or
succeeding minimum were analyzed post hoc for statistical
differences using the Student Newman-Keuls sequential range
test. The a-value was set at 0.05 for these post hoc analyses.
Results
Experiment 1: Temporal Profiling of miR-142-3p
Expression in SCN cells in vivo and in vitro
Prior to determining whether miR-142-3p expression in SCN
cells fluctuates on a circadian basis, we analyzed the promoter
region of this miRNA for evidence of E-box or CRE-box elements
which are known to mediate clock- and light-controlled transcrip-
miR-142-3p Modulation of BMAL1 in SCN Pacemaker
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tion, respectively. The presence of a canonical, CACGTG E-box
element was identified ,1.5 Kb upstream of the miR-142 locus
and analysis of syntenic regions indicated that this regulatory
element is highly conserved among mammalian lineages.
Because identification of an E-box element in the promoter
region of miR-142 suggests that its transcription may be clock-
controlled, we next examined the temporal profile of miR-142-3p
expression in the SCN in vivo. During exposure to DD, the relative
abundance of miR-142-3p (normalized to U6 snRNA) in the
mouse SCN was marked by circadian variation (p,0.01) with peak
expression occurring early in subjective day and low levels
throughout the early and middle portions of the subjective night
(Fig. 1). The rhythmic peak in SCN expression of miR-142-3p at
CT 3 was significantly (p,0.05) and about 2-fold greater than the
succeeding minima observed during the early subjective night at
CT 15. Parallel analysis of Bmal1 expression in the same samples
revealed that SCN content of this clock gene mRNA was
characterized by a circadian profile (p,0.01) similar to that
reported previously [36,37]. The peak in SCN expression of Bmal1
mRNA during the late subjective night at CT 23 was significantly
greater (p,0.01) than that observed during the preceding minima.
The phase relationship between circadian oscillations in Bmal1
mRNA and miR-142-3p expression in the mouse SCN is
noteworthy; the rising phase and peak of the Bmal1 rhythm
occurred in advance of peak miR-142-3p expression in the SCN,
raising the possibility that Bmal1 may play a role in the activation
of miR-142-3p transcription.
Studies using immortalized mPer2Luc SCN cells were subse-
quently conducted to determine whether levels of mature miR-
142-3p are also rhythmically regulated in vitro because this cell line
has been shown to retain the endogenous oscillatory properties of
the SCN in vivo (ensemble rhythms of Farnell et al. [29]). Similar
to the temporal profile observed in the mouse SCN, miR-142-3p
expression (normalized to U6 snRNA) oscillated with a circadian
periodicity (p,0.01) in cultures of mPer2Luc SCN cells (Fig. 2A).
The amplitude of this circadian rhythm in miR-142-3p levels was
robust, with 3- to 4-fold differences between peak and trough
values. The rhythmic peak of miR-142-3p expression in mPer2Luc
SCN cells at 12 h was significantly greater (p,0.01) than the
minima observed at 20 h. Circadian variation in Bmal1 expression
was also observed in the same mPer2Luc SCN cultures (p,0.01),
with circadian peaks in Bmal1 mRNA levels at 0 h and 24 h that
were significantly greater (p,0.01) than the nadir observed at 8 h.
The Bmal1 and miR-142-3p rhythms in mPer2Luc SCN cells were
marked by overt phase differences such that the oscillation in
Bmal1 mRNA levels was antiphasic to the circadian profile in miR-
142-3p expression (Fig. 2A). This phase relationship between
Bmal1 mRNA and miR-142-3p rhythms in SCN cells in vitro
differed from that observed in the SCN in vivo. Although the basis
for the phase differences between in vivo and in vitro SCN rhythms
is unknown, an important consideration is that analysis of the
mouse SCN was conducted following stable entrainment to a
strong synchronizing signal (i.e., LD cycle) whereas experiments
with mPer2Luc SCN cultures were performed in the absence of
advance exposure to a defined phase-resetting stimulus (e.g., serum
shock).
To verify that the observed miR-142-3p rhythm in SCN cells is
under control of the circadian clock, the temporal profile of miR-
142-3p expression was analyzed in a SCN cell line derived from
mice with targeted disruption of Per1 and Per2 genes (Per1ldc/
Per2ldc). These mutant mice have been shown to exhibit an
arrhythmic behavioral phenotype [38] and our previous findings
indicate that SCN-specific circadian pacemaking function is
similarly abolished in immortalized Per1ldc/Per2ldc SCN cells [29].
Bmal1 mRNA levels in Per1ldc/Per2ldc SCN cultures fluctuated over
time but this variation was not characterized by circadian or other
rhythmic harmonics. MiR-142-3p expression in the same cultures
remained largely at constant levels and showed no significant
Figure 1. Temporal patterns of miR-142-3p and Bmal1 expression in the mouse SCN. Symbols denote real-time PCR determinations (mean
6 SEM) of miR-142-3p (red) and Bmal1 mRNA (black) levels at 4-hour intervals in the SCN (n= 4-5) of mice exposed to constant darkness (DD). The
plotted values correspond to the ratios of miR-142-3p signal normalized to U6 snRNA levels and of Bmal1/Ppia mRNA signal in which the maximal
value for each gene was set at 100%. Asterisks indicate time points during which peak levels were significantly greater (p,0.05) than those observed
during preceding or succeeding minima.
doi:10.1371/journal.pone.0065300.g001
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evidence of circadian rhythmicity (p.0.05) (Fig. 2B), indicating
that the miR-142-3p oscillation observed in immortalized SCN
cells in vitro is indeed clock-controlled.
Experiment 2: Mutagenic Analysis of Putative Binding
Sites Mediating miR-142-3p-induced Repression of Bmal1
39 UTR Activity
Our previous findings indicate that miR-142-3p represses Bmal1
39 UTR activity [26]. Based on target prediction algorithms, this
miR-142-3p-mediated repression is predicted to occur via two
consensus binding sites on the Bmal1 39 UTR. To evaluate the
specificity and relative contribution of these predicted miR-142-3p
binding sites, we analyzed luciferase-reported Bmal1 39 UTR
activity in HEK293 cells co-transfected with the pEZX-MR04
miR-142 expression vector and constructs for either full-length
Bmal1 39 UTR (WT) or mutants with independent site-directed
deletions of nucleotides 1–7 (c.1_7del) or nucleotides 335–357
which includes the second seed region and putative 39 supple-
mentary or compensatory elements (c.335_357del) or combined
deletions of both loci (c.1_7del+c.335_357del) (Fig. 3A). Consistent
with our previous results [26], miR-142-3p overexpression
produced significant decreases (p,0.01) of ,60% in luciferase-
reported bioluminescence in WT Bmal1 39 UTR-expressing
HEK293 cells relative to that found in cells transfected with the
control vector (Fig. 3B). In HEK293 cells co-transfected with
Figure 2. Temporal patterns of miR-142-3p and Bmal1 expression in immortalized SCN cells in vitro. Symbols denote real-time PCR
determinations (mean 6 SEM) of miR-142-3p (red) and Bmal1 mRNA (black) levels at 4-hour intervals in cultures (n = 4–5) of mPer2Luc SCN cells (A)
and immortalized SCN cells (Per1ldc/Per2ldc) with targeted disruption of Per1 and Per2 (B). The plotted values correspond to the ratios of miR-142-3p
signal normalized to U6 snRNA levels and of Bmal1/Ppia mRNA signal in which the maximal value for each gene was set at 100%. Asterisks indicate
time points during which peak levels were significantly greater (p,0.05) than those observed during preceding or succeeding minima.
doi:10.1371/journal.pone.0065300.g002
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either the c.1_7del or c.335_357del Bmal1 39 UTR, overexpression
of miR-142-3p similarly induced a significant (p,0.05) reduction
in luciferase-mediated bioluminescence relative to control trans-
fections but the amplitude of this effect was diminished (,30%) in
comparison to that observed for the full-length Bmal1 39 UTR.
Combined deletion of both 39 UTR target sites
(c.1_7del+c.335_357del) completely abolished repression of the
Bmal1 39 UTR in response to miR-142-3p-overexpression as no
significant differences in bioluminescence (p = 0.33) were observed
in cells transfected with control vector or the c.1_7del+c.335_357del
construct (Fig. 3B). Collectively, these findings indicate that both of
the putative miR-142-3p binding sites contribute equally to the
repression of the Bmal1 39 UTR.
In addition to miR-142-3p, miR-494 has also been shown to
repress Bmal1 39 UTR activity [26], potentially by interacting with
nucleotides 473-495. Consequently, we examined the effects of
miR-494 on full-length and mutant (c.1_7del+c.335_357del) Bmal1
39 UTR activity to verify the specificity of the miR-142-3p binding
sites at nucleotides 1–7 and 335–357. In HEK293 cells co-
transfected with the c.1_7del+c.335_357del 39 UTR construct,
overexpression of miR-494 induced a significant reduction
(p,0.01) of ,35% in luciferase-reported bioluminescence relative
to that found in cells transfected with the control vector (Fig. 3C).
Importantly, this miR-494-mediated repression of the Bmal1 39
UTR with combined deletion of the putative miR-142-3p binding
sites was similar to that observed for the full-length 39 UTR
construct, suggesting that both mutagenized loci are specific
targets for the action of miR-142-3p.
Experiment 3: Effects of miR-142-3p Overexpression on
the Circadian Regulation of BMAL1 Protein Levels in SCN
cells in vitro
To investigate functional implications of miR-142-3p in the
regulation of SCN clock gene oscillations, we next determined
Figure 3. Effects of binding site mutagenesis on miR-142-3p-induced repression of Bmal1 39 UTR activity. (A) Diagrammatic
representation of WT and mutagenized Bmal1 39 UTR constructs with independent site-directed deletions of predicted miR-142-3p binding sites. (B)
Normalized bioluminescence from HEK293 cells co-transfected with pEZX-MR04 miR-142 expression vector and with either the target control, full-
length Bmal1 (WT), Bmal1 c.1_7del, Bmal1 c.335_357del or Bmal1 c.1_7del+c.335_357del miRNA 39 UTR target clones. (C) Normalized bioluminescence
from HEK293 cells co-transfected with pEZX-MR04 miR-494 expression vector with either the target control, full-length Bmal1 (WT), Bmal1 c.1_7del,
Bmal1 c.335_357del or Bmal1 c.1_7del+c.335_357del miRNA 39 UTR target clones. Bars represent mean (6SEM) determinations of luciferase
bioluminescence for each treatment group (n = 4). The plotted values correspond to the ratios of firefly luciferase signal normalized to Renilla
luciferase activity in the same sample and are represented as a percentage of the average signal for control vector transfectants. Asterisks denote
comparisons in which normalized bioluminescence for a given treatment group was significantly reduced (p,0.05) relative to that observed in
control vector transfectants.
doi:10.1371/journal.pone.0065300.g003
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whether constitutive overexpression of miR-142-3p in immortal-
ized mPer2Luc SCN cells affects the circadian rhythm in endoge-
nous BMAL1 protein levels. In cultured mPer2Luc SCN cells
transfected with the scrambled control vector, BMAL1 content
varied significantly (p,0.001) over time (Fig. 4). The rhythmic
peak in BMAL1 protein levels at 20 h was significantly (p,0.01)
and about 3-fold higher than the succeeding trough observed 8 h
later. In comparison with control cultures, the BMAL1 rhythm
was abolished in miR-142-3p-transfected mPer2Luc SCN cultures as
content of this clock gene protein remained at intermediate levels
with no significant variation (p.0.05). The disruption of
rhythmicity induced by miR-142-3p overexpression was associated
with a significant decrease (p,0.05) in BMAL1 protein levels at
20 h relative to peak values observed at this timepoint in control
cultures.
Discussion
In the SCN, circadian oscillations in many of the core clock
genes as well as clock-controlled genes are essential to the
autonomous oscillator properties of individual cells and their
ensemble function as the master circadian pacemaker in mam-
mals. Recent evidence indicates that miRNAs play a role in the
post-transcriptional processes that mediate the oscillatory proper-
ties and timekeeping function of core clock genes. In NIH/3T3
fibroblasts, overexpression of the miR-192/194 cluster represses
the 39 UTRs of Per1, Per2 and Per3 and shortens the circadian
period of the Bmal1 mRNA rhythm [25]. The current study
provides the first evidence for the role of miRNAs in the regulation
of specific clock genes and their cyclical modulation in the master
pacemaker of mammalian circadian rhythms. Similar to many of
its endogenous biological processes, SCN expression of miR-142-
3p fluctuates rhythmically and circadian regulation of this miRNA
is dependent on the integrity of the molecular clockworks. In
addition, miR-142-3p modulates Bmal1 expression in the mouse
SCN and plays a role in the circadian control of this clock gene as
over-expression abolishes the rhythm in BMAL1 protein accumu-
lation. Because Bmal1 is widely expressed and rhythmically
regulated in most cells and tissues throughout the body [39],
miR-142-3p may play a similar modulatory role in the post-
transcriptional regulation of core molecular components in
peripheral clocks.
The phase relationship between miR-142-3p and Bmal1
rhythms in the SCN is compatible with our evidence for the
function of this miRNA as a post-transcriptional repressor of
Bmal1. In the SCN, miR-142-3p levels reached peak values during
the early subjective day when Bmal1 expression was low. In
conjunction with evidence that miR-142-3p is a bona-fide clock-
controlled gene, the localization of a conserved, canonical E-box
(CANNTG) element ,1.5 kb upstream of the miR-142 locus
suggests that its clock gene target may feed back and positively
regulate the transcription of this miRNA through the formation of
CLOCK-BMAL1 heterodimer complexes. Based on the observa-
tion that CLOCK-BMAL1 abundance fluctuates in the mouse
SCN with peak levels occurring at CT 0 [37], it appears that the
putative timing of these positive transcriptional regulatory
complexes is appropriately phased in advance of the zenith in
SCN miR-142-3p expression at CT 3. Relative to other miRNA-
target relationships, miR-142-3p and Bmal1 are thus unique
because the miRNA represses its target gene but the target also
drives expression of the miRNA.
In mammals, the activity of miRNAs as post-transcriptional
repressors is primarily dependent on conserved complementarity
between 39 UTR elements of the target mRNA and 7-8mer sites in
the seed region comprising nucleotides 2–8 of the miRNA
[33,40,41]. In the Bmal1 39 UTR, nucleotides 1–7 are comple-
mentary to seed region of miR-142-3p. Consistent with the
predicted significance of seed region interactions in functional
mRNA–miRNA pairing, deletion of the first seven nucleotides in
the Bmal1 39 UTR abated miR-142-3p-mediated repression by
,50%. In addition to this portion of the 39 UTR, deletion of a
highly conserved, canonical miRNA recognition element (MRE)
at nucleotides 335–357 encompassing an octamer complementary
to the seed region of miR-142-3p also yielded a comparable
reduction (,50%) in the repressive effect of this miRNA on Bmal1
39 UTR activity. Site-directed deletion of both putative MREs at
nucleotides 1–7 and 335–357 completely abolished miR-142-3p-
induced, but not miR-494-mediated, inhibition of Bmal1 39 UTR
activity. Thus, these observations provide primary evidence
indicating that two independent MREs on the Bmal1 39 UTR
are responsible for binding miR-142-3p and both contribute
equally to its modulatory effects on 39 UTR activity. The high
degree of conservation for miR-142-3p and the two MREs on the
Bmal1 39 UTR suggest that miR-142-3p may contribute to the
feedback modulation of Bmal1 and perhaps other core elements of
the molecular clockworks in the SCN across different mammalian
species.
Figure 4. Effects of miR-142-3p overexpression on the
circadian rhythm of BMAL1 protein content in immortalized
SCN cells in vitro. Representative Western blot results and densito-
metric determinations of BMAL1 protein levels at 4-hour intervals in
cultures (n = 4–5) of mPer2Luc SCN cells transfected with pEZX-MR04
control miRNA expression vector (CONT) or pEZX-MR04 miR-142
expression vector (miR-142). The plotted values represent the relative
optical density (mean6 SEM) and correspond to the ratios of BMAL1/b-
actin immunoreactive signal in each sample. The asterisk indicates that
the peak in BMAL1 protein levels at 20 hr was significantly greater
(p,0.05) than that observed during succeeding minima.
doi:10.1371/journal.pone.0065300.g004
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Because miRNAs function as molecular switches controlling
expression of hundreds of genes [42,43], the impact of miR-142-
3p and its circadian modulation may extend beyond the regulation
of Bmal1. In this regard, miR-142-3p has also been shown to
modulate cAMP levels by targeting adenylate cyclase 9 in T-cells
[43,44]. In the context of the present study, the possible
modulation of this second messenger by miR-142-3p is intriguing
because cAMP levels in the rat SCN fluctuate on a circadian basis
with bimodal peaks during the late subjective day and late
subjective night [45] and cAMP pathways are involved in
regulating the SCN circadian rhythms [45,46]. Hence, miR-142-
3p may play a role in the circadian physiology of the SCN by
regulating not only the core clock gene, Bmal1, but also clock-
controlled outputs like cAMP so as to provide feedback capable of
resetting and/or fine-tuning the clock mechanism.
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